Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?

导出 OA

翻译打印收藏纠错

作者： Leon M T,Dicks ^[1] ; Shelly M,Deane ^[2] ; Matthew J,Grobbelaar ^[2]

作者单位： Department of Microbiology, Stellenbosch University, Stellenbosch, 7600, South Africa. LMTD@sun.ac.za. ^[1] Department of Microbiology, Stellenbosch University, Stellenbosch, 7600, South Africa. ^[2]

关键词 COVID-19 Gut microbiota Ivermectin SARS-CoV-2

主题词动物(Animals);抗病毒药(Antiviral Agents);伊维菌素(Ivermectin)

DOI 10.1007/s12602-022-09925-5

PMID 35218001

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Probiotics and antimicrobial proteins

2022年14卷2期

217-223页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?

Probiotics and antimicrobial proteins

相似文献

Probiotics and antimicrobial proteins

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?

Probiotics and antimicrobial proteins

相似文献

Probiotics and antimicrobial proteins

相关期刊

检索历史清除